Rockwell Medical (RMTI) Capital Expenditures (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Capital Expenditures came in at $425000.0 in Q1 2026, up 574.6% YoY from $63000.0 in Q1 2025, and up 394.19% on a QoQ basis from $86000.0 in Q4 2025.
Rockwell Medical (RMTI) Capital Expenditures (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Capital Expenditures data on file, last reported at $425000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 574.6% year-over-year to $425000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $904000.0 (down 3.32% YoY) and the FY2025 annual result came in at $542000.0, down 46.39% from the prior year.
- Capital Expenditures improved to $425000.0 in Q1 2026, from $86000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $425000.0 in Q1 2026 to a low of -$80000.0 in Q3 2022.
- A 5-year average of $149588.2 and a median of $139000.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures slumped 162.99% — and 2024, when it soared 1093.75%.
- Tracing RMTI's Capital Expenditures over 5 years: stood at $281000.0 in 2022, then sank by 84.7% to $43000.0 in 2023, then soared by 818.6% to $395000.0 in 2024, then tumbled by 78.23% to $86000.0 in 2025, then jumped by 394.19% to $425000.0 in 2026.
- The last three Capital Expenditures figures came in at $425000.0 (Q1 2026), $86000.0 (Q4 2025), and $229000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | 617,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 617,000.00 |
| Jun 30, 2026 | 617,000.00 |
| Mar 31, 2026 | 425,000.00 |
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Jun 30, 2025 | 164,000.00 |
| Jun 30, 2025 | 164,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Dec 31, 2024 | 395,000.00 |
| Dec 31, 2024 | 395,000.00 |
| Sep 30, 2024 | 191,000.00 |
| Sep 30, 2024 | 191,000.00 |
| Jun 30, 2024 | 286,000.00 |
| Jun 30, 2024 | 286,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Mar 31, 2024 | 139,000.00 |